Pharmaceutical aspects of paclitaxel
- 1 October 1998
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 172 (1-2) , 1-15
- https://doi.org/10.1016/s0378-5173(98)00188-4
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Phase I Study of Paclitaxel by Three‐hour Infusion: Hypotension Just after Infusion Is One of the Major Dose‐limiting ToxicitiesJapanese Journal of Cancer Research, 1995
- Interaction of taxol and other anticancer drugs with α-cyclodextrinJournal of Pharmaceutical and Biomedical Analysis, 1995
- Highly water soluble taxol derivatives: 2′-polyethyleneglycol esters as potential prodrugsBioorganic & Medicinal Chemistry Letters, 1994
- Polymer ConjugatesClinical Pharmacokinetics, 1994
- Chemistry and Biology of TaxolAngewandte Chemie International Edition in English, 1994
- Drug-polymer conjugatesAnti-Cancer Drugs, 1992
- Taxol: Twenty Years Later, the Story UnfoldsJNCI Journal of the National Cancer Institute, 1991
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Components of Podophyllin. V. The Constitution of Podophyllotoxin1Journal of the American Chemical Society, 1951
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948